| Q36302679 | A B-1a cell subset induces Foxp3(-) T cells with regulatory activity through an IL-10-independent pathway |
| Q35927524 | A CD25− Positive Population of Activated B1 Cells Expresses LIFR and Responds to LIF |
| Q64075176 | A Pathogenic Role for Splenic B1 Cells in SIV Disease Progression in Rhesus Macaques |
| Q44158836 | A Virtual Culture of CD4+ T Lymphocytes |
| Q42568871 | A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand |
| Q30934051 | A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice. |
| Q51651115 | A robust model to describe the differentiation of T-helper cells |
| Q35627702 | A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus |
| Q90216608 | Abnormal numbers of CD4+ T lymphocytes and abnormal expression of CD4+ T lymphocyte‑secreted cytokines in patients with immune‑related haemocytopenia |
| Q26752542 | An Overview of B-1 Cells as Antigen-Presenting Cells |
| Q53254779 | An unexpected requirement for CD4+ T cells in anti‐glycolipid antibody responses |
| Q38174880 | Atypical Response of B-1 Cells to BCR Ligation: A Speculative Model |
| Q38961202 | B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. |
| Q83516331 | B Cells as a Therapeutic Target for IFN-β in Relapsing–Remitting Multiple Sclerosis |
| Q38095860 | B cell biology: implications for treatment of systemic lupus erythematosus |
| Q39122679 | B cell contribution of the CD4+ T cell inflammatory phenotypes in systemic lupus erythematosus |
| Q30423324 | B cell subsets in atherosclerosis |
| Q37308252 | B cells and immunological tolerance. |
| Q37995319 | B cells as effectors and regulators of autoimmunity |
| Q37603296 | B cells as therapeutic targets in SLE. |
| Q92135995 | B-1 Cells May Drive Macrophages Susceptibility to Trypanosoma cruzi Infection |
| Q37497841 | B-1a B cells regulate T cell differentiation associated with pregnancy disturbances |
| Q37663776 | B-1a cell diversity: nontemplated addition in B-1a cell Ig is determined by progenitor population and developmental location |
| Q37190057 | B1a cells play a pathogenic role in the development of autoimmune arthritis. |
| Q30370021 | B2 cells suppress experimental abdominal aortic aneurysms. |
| Q33960021 | Bridging innate and adaptive antitumor immunity targeting glycans. |
| Q41227565 | CD19 Expression in B Cells Regulates Atopic Dermatitis in a Mouse Model |
| Q37238275 | CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis |
| Q33556996 | Characterization of c-Maf+Foxp3- Regulatory T Cells Induced by Repeated Stimulation of Antigen-Presenting B Cells |
| Q37405410 | Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells |
| Q38366479 | Contribution of B-1a cells to systemic lupus erythematosus in the NZM2410 mouse model |
| Q38170793 | Contributions of B cells to lupus pathogenesis |
| Q36218400 | Cyclin-Dependent Kinase Inhibitor Cdkn2c Deficiency Promotes B1a Cell Expansion and Autoimmunity in a Mouse Model of Lupus |
| Q37176288 | Cyclin-dependent kinase inhibitor Cdkn2c regulates B cell homeostasis and function in the NZM2410-derived murine lupus susceptibility locus Sle2c1 |
| Q46435822 | Developmental expression of B cell molecules in equine lymphoid tissues. |
| Q57141996 | Differential Influence on Regulatory B Cells by T2 Cytokines Affects Protection in Allergic Airway Disease |
| Q51040316 | Differential Role of B Cells and IL-17 Versus IFN-γ During Early and Late Rejection of Pig Islet Xenografts in Mice. |
| Q36868786 | Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells |
| Q27000764 | Expanding the Clinical Indications for α1-Antitrypsin Therapy |
| Q36723572 | Expansion of B-1a Cells with Germline Heavy Chain Sequence in Lupus Mice |
| Q64075206 | Human B-1 Cells and B-1 Cell Antibodies Change With Advancing Age |
| Q24594899 | Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70− |
| Q35600416 | Human B‐1 cells take the stage |
| Q35988077 | Human b1 cell frequency: isolation and analysis of human b1 cells. |
| Q35115832 | Immunoglobulin secretion by B1 cells: Differential intensity and IRF4‐dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells |
| Q83770166 | Immunologic Reconstitution After Rituximab in Systemic Lupus Erythematosus: Why Should We Care? |
| Q50930204 | Immunophenotyping of putative human B1 B cells in healthy controls and common variable immunodeficiency (CVID) patients. |
| Q33950788 | In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response |
| Q36173295 | Increased NHC Cells in the Peritoneal Cavity of Plasmacytoma Susceptible BALB/c Mouse |
| Q36223923 | Induction of Th17 cell differentiation by B-1 cells |
| Q37436035 | Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets |
| Q34927610 | L2pB1: a new player in autoimmunity |
| Q49164628 | Linking autoimmunity to the origin of the adaptive immune system |
| Q37980951 | Malaria's deadly secret: a skin stage |
| Q35747533 | Multiple mechanisms of immune suppression by B lymphocytes |
| Q36938974 | Natural and induced B-1 cell immunity to infections raises questions of nature versus nurture |
| Q36296344 | New insights into heterogeneity of peritoneal B-1a cells |
| Q37223511 | Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo |
| Q51790222 | Novel functions of murine B1 cells: Active phagocytic and microbicidal abilities |
| Q40109527 | PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism |
| Q36803471 | Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis |
| Q42261106 | Peritoneal cavity B-1a cells promote peripheral CD4+ T-cell activation |
| Q37079426 | Phenotypic and functional heterogeneity of human memory B cells |
| Q42114726 | Pivotal advance: peritoneal cavity B-1 B cells have phagocytic and microbicidal capacities and present phagocytosed antigen to CD4+ T cells |
| Q40735115 | Plasma cell alloantigen ENPP1 is expressed by a subset of human B cells with potential regulatory functions |
| Q33829700 | Rationale for B cell targeting in SLE |
| Q40343851 | Recombinant Phage Elicits Protective Immune Response against Systemic S. globosa Infection in Mouse Model |
| Q37541443 | Reference Values for a Panel of Cytokinergic and Regulatory Lymphocyte Subpopulations. |
| Q47154701 | Regulatory T cells induced by B cells: a novel subpopulation of regulatory T cells |
| Q54251519 | Relative Contributions of B Cells and Dendritic Cells from Lupus-Prone Mice to CD4+ T Cell Polarization. |
| Q48140617 | S1P Signalling Differentially Affects Migration of Peritoneal B Cell Populations In Vitro and Influences the Production of Intestinal IgA In Vivo. |
| Q42249912 | Skewed B cell differentiation affects lymphoid organogenesis but not T cell-mediated autoimmunity |
| Q36093770 | T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis |
| Q36761844 | Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges |
| Q37173912 | Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice |
| Q34821636 | The NZM2410-derived lupus susceptibility locus Sle2c1 increases Th17 polarization and induces nephritis in fas-deficient mice |
| Q41687121 | The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens |
| Q36296618 | The role of B-1 cells in inflammation |
| Q34462156 | The significance of non-T-cell pathways in graft rejection: implications for transplant tolerance |
| Q51282774 | Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild‐type and B‐cell‐deficient NOD mice |
| Q36504624 | Treatment targets in systemic lupus erythematosus: biology and clinical perspective |
| Q38100593 | Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment. |
| Q38150849 | Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models |
| Q38432504 | α-1 Antitrypsin Promotes Semimature, IL-10–Producing and Readily Migrating Tolerogenic Dendritic Cells |